161 related articles for article (PubMed ID: 8026885)
1. Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens.
VandenDriessche T; Geldhof A; Bakkus M; Toussaint-Demylle D; Brijs L; Thielemans K; Verschueren H; De Baetselier P
Int J Cancer; 1994 Jul; 58(2):217-25. PubMed ID: 8026885
[TBL] [Abstract][Full Text] [Related]
2. Introduction of the interferon gamma gene into mouse T lymphoma cells with low MHC class I-expression results in selective induction of H-2Dk and concomitant enhanced metastasis.
Geldhof AB; VandenDriessche T; Opdenakker G; De Baetselier P
Cancer Immunol Immunother; 1996 Jul; 42(6):329-38. PubMed ID: 8830735
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens.
VandenDriessche T; Bakkus M; Toussaint-Demylle D; Thielemans K; Verschueren H; De Baetselier P
Clin Exp Metastasis; 1994 Jan; 12(1):73-83. PubMed ID: 8287623
[TBL] [Abstract][Full Text] [Related]
4. Effects of altered antigen processing on H-2Dk mediated NK inhibition in a murine T lymphoma model.
Van Ginderachter J; Raes G; Devoogdt N; De Baetselier F; Geldhof A
Adv Exp Med Biol; 1998; 451():237-40. PubMed ID: 10026878
[No Abstract] [Full Text] [Related]
5. NK sensitivity, H-2 expression and metastatic potential: analysis of H-2Dk gene transfected fibrosarcoma cells.
Gopas J; Rager-Zisman B; Har-Vardi I; Hammerling GJ; Bar-Eli M; Segal S
J Immunogenet; 1989; 16(4-5):305-13. PubMed ID: 2639905
[TBL] [Abstract][Full Text] [Related]
6. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
[TBL] [Abstract][Full Text] [Related]
7. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity.
Geldhof AB; Raes G; Bakkus M; Devos S; Thielemans K; De Baetselier P
Cancer Res; 1995 Jul; 55(13):2730-3. PubMed ID: 7540948
[TBL] [Abstract][Full Text] [Related]
8. Immunogenization of a murine T-cell lymphoma via transfection with interferon-gamma.
Raes G; Geldhof A; Vanden Driessche T; Opdenakker G; Sibille C; De Baetselier P
Leukemia; 1995 Oct; 9 Suppl 1():S121-7. PubMed ID: 7475304
[TBL] [Abstract][Full Text] [Related]
9. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
10. Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency.
Katzav S; Segal S; Feldman M
J Natl Cancer Inst; 1985 Aug; 75(2):307-18. PubMed ID: 3894752
[TBL] [Abstract][Full Text] [Related]
11. Introduction of the H-2Dk gene into a class I-negative tumor cell line confers interferon-gamma inducibility upon the silent endogenous H-2Kk gene.
Rosenthal LA; Klyczek KK; Blank KJ
Cell Immunol; 1992 Nov; 145(1):43-55. PubMed ID: 1423645
[TBL] [Abstract][Full Text] [Related]
12. Multiple effects of transfection with interleukin 2 and/or interferon gamma on the behavior of mouse T lymphoma cells.
Geldhof AB; Van Ginderachter J; Vandersteen P; Raes G; De Baetselier P
Clin Exp Metastasis; 1998 Jul; 16(5):447-59. PubMed ID: 10091940
[TBL] [Abstract][Full Text] [Related]
13. The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis.
Chiang EY; Henson M; Stroynowski I
J Immunol; 2002 Mar; 168(5):2200-11. PubMed ID: 11859106
[TBL] [Abstract][Full Text] [Related]
14. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
15. Association between MHC class I antigen expression and malignancy of murine T lymphoma variants.
Vanden Driessche T; Verschueren H; De Baetselier P
Invasion Metastasis; 1990; 10(2):65-85. PubMed ID: 2307562
[TBL] [Abstract][Full Text] [Related]
16. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the H-2Dk MHC class-I antigen and tissue inhibitor of metalloproteinases in metastatic and nonmetastatic T-10 fibrosarcoma cells.
Har-Vardi I; Gopas J; Rager-Zisman B; Hammerling GJ; Segal S; Aboud M
Invasion Metastasis; 1992; 12(5-6):301-8. PubMed ID: 1298741
[TBL] [Abstract][Full Text] [Related]
18. Alteration of the metastatic potential of line 1 lung carcinoma cells: opposite effects of class I antigen induction by interferons versus DMSO or gene transfection.
Cerosaletti KM; Blieden TM; Harwell LW; Welsh KM; Frelinger JG; Lord EM
Cell Immunol; 1990 May; 127(2):299-310. PubMed ID: 1691690
[TBL] [Abstract][Full Text] [Related]
19. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
Karlhofer FM; Ribaudo RK; Yokoyama WM
Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
[TBL] [Abstract][Full Text] [Related]
20. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
